Health Canada drug identification number

DIN 02390299 — MYLAN-RILUZOLE 50 MG

MYLAN-RILUZOLE is a tablet of Riluzole marketed by MYLAN PHARMACEUTICALS ULC. The full Riluzole monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02390299
Brand name
MYLAN-RILUZOLE
Active ingredient
Riluzole
Strength
50 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
MYLAN PHARMACEUTICALS ULC
Health Canada status
MARKETED
Drug class
Antiglutamate agent (glutamate release inhibitor) for amyotrophic lateral sclerosis

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Riluzole products

DINBrandStrengthFormManufacturerStatus
02352583 APO-RILUZOLE 50 MG TABLET APOTEX INC MARKETED
02242763 RILUTEK 50 MG TABLET SANOFI-AVENTIS CANADA INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.